FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.0  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) IPS terminology module (core metadata concept)

57868 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some
Members acceptabilityId
Metastatic malignant neoplasm to spine Acceptable (foundation metadata concept)
Metastatic malignant neoplasm to testis Preferred (foundation metadata concept)
Metastatic malignant neoplasm to testis (disorder) Preferred (foundation metadata concept)
Metastatic malignant neoplasm to the retroperitoneum Acceptable (foundation metadata concept)
Metastatic malignant neoplasm to urinary bladder Preferred (foundation metadata concept)
Metastatic malignant neoplasm to urinary bladder (disorder) Preferred (foundation metadata concept)
Metastatic malignant neoplasm to vertebral column Preferred (foundation metadata concept)
Metastatic malignant neoplasm to vertebral column (disorder) Preferred (foundation metadata concept)
Metastatic neoplasm Acceptable (foundation metadata concept)
Metastatic neoplasm (disease) Acceptable (foundation metadata concept)
Metastatic sarcoma Preferred (foundation metadata concept)
Metastatic sarcoma (disorder) Preferred (foundation metadata concept)
Metastatic squamous cell carcinoma Acceptable (foundation metadata concept)
Metastatic squamous cell carcinoma Preferred (foundation metadata concept)
Metastatic squamous cell carcinoma (disorder) Preferred (foundation metadata concept)
Metastatic tumor in kidney Acceptable (foundation metadata concept)
Metastatic tumor of bone Acceptable (foundation metadata concept)
Metastatic tumor to bladder Acceptable (foundation metadata concept)
Metastatic tumor to prostate Acceptable (foundation metadata concept)
Metastatic tumor to testis Acceptable (foundation metadata concept)
Metatarsal Acceptable (foundation metadata concept)
Metatarsal bone Acceptable (foundation metadata concept)
Metatarsal bone fracture Preferred (foundation metadata concept)
Metatarsal bone fracture (disorder) Preferred (foundation metadata concept)
Metatarsal bone structure Preferred (foundation metadata concept)
Metatarsal bone structure (body structure) Preferred (foundation metadata concept)
Metatarsalgia Preferred (foundation metadata concept)
Metatarsalgia (finding) Preferred (foundation metadata concept)
Metatarsophalangeal joint of fifth toe Acceptable (foundation metadata concept)
Metatarsophalangeal joint of great toe Acceptable (foundation metadata concept)
Metatarsophalangeal joint structure of fifth toe Preferred (foundation metadata concept)
Metatarsophalangeal joint structure of fifth toe (body structure) Preferred (foundation metadata concept)
Metatarsus adductus Preferred (foundation metadata concept)
Metatarsus adductus (disorder) Preferred (foundation metadata concept)
Metformin Preferred (foundation metadata concept)
Metformin (substance) Preferred (foundation metadata concept)
Metformin hydrochloride Preferred (foundation metadata concept)
Metformin hydrochloride (substance) Preferred (foundation metadata concept)
Metformin hydrochloride 500 mg oral tablet Preferred (foundation metadata concept)
Metformin only product Preferred (foundation metadata concept)
Methacrylate Preferred (foundation metadata concept)
Methacrylate (substance) Preferred (foundation metadata concept)
Methacrylate ester Preferred (foundation metadata concept)
Methacrylate ester (substance) Preferred (foundation metadata concept)
Methadone Preferred (foundation metadata concept)
Methadone (substance) Preferred (foundation metadata concept)
Methadone hydrochloride Preferred (foundation metadata concept)
Methadone hydrochloride (substance) Preferred (foundation metadata concept)
Methadone hydrochloride 1 mg/mL oral solution Preferred (foundation metadata concept)
Methadone hydrochloride 10 mg oral tablet Preferred (foundation metadata concept)
Methadone hydrochloride 10 mg/mL oral solution Preferred (foundation metadata concept)
Methadone hydrochloride 2 mg/mL oral solution Preferred (foundation metadata concept)
Methadone hydrochloride 5 mg oral tablet Preferred (foundation metadata concept)
Methadone hydrochloride 5 mg/mL oral solution Preferred (foundation metadata concept)
Methadone only product Preferred (foundation metadata concept)
Methemoglobinemia Preferred (foundation metadata concept)
Methemoglobinemia (disorder) Preferred (foundation metadata concept)
Methenamine Preferred (foundation metadata concept)
Methenamine (substance) Preferred (foundation metadata concept)
Methicillin resistant Staphylococcus Preferred (foundation metadata concept)
Methicillin resistant Staphylococcus (organism) Preferred (foundation metadata concept)
Methicillin resistant Staphylococcus aureus Preferred (foundation metadata concept)
Methicillin resistant Staphylococcus aureus (organism) Preferred (foundation metadata concept)
Methicillin resistant Staphylococcus aureus infection Preferred (foundation metadata concept)
Methicillin resistant Staphylococcus aureus infection (disorder) Preferred (foundation metadata concept)
Methicillin susceptible Staphylococcus aureus Preferred (foundation metadata concept)
Methicillin susceptible Staphylococcus aureus (organism) Preferred (foundation metadata concept)
Methimazole Preferred (foundation metadata concept)
Methimazole 10 mg oral tablet Preferred (foundation metadata concept)
Methimazole 20 mg oral tablet Preferred (foundation metadata concept)
Methimazole 5 mg oral tablet Preferred (foundation metadata concept)
Methimazole only product Preferred (foundation metadata concept)
Method Preferred (foundation metadata concept)
Method (attribute) Preferred (foundation metadata concept)
Methotrexate Preferred (foundation metadata concept)
Methotrexate (as methotrexate sodium) 100 mg/mL solution for injection Preferred (foundation metadata concept)
Methotrexate (as methotrexate sodium) 2.5 mg oral tablet Preferred (foundation metadata concept)
Methotrexate (as methotrexate sodium) 2.5 mg/mL solution for injection Preferred (foundation metadata concept)
Methotrexate (as methotrexate sodium) 20 mg/mL solution for injection Preferred (foundation metadata concept)
Methotrexate (as methotrexate sodium) 25 mg/mL solution for injection Preferred (foundation metadata concept)
Methotrexate (substance) Preferred (foundation metadata concept)
Methotrexate disodium Acceptable (foundation metadata concept)
Methotrexate only product Preferred (foundation metadata concept)
Methotrexate sodium Preferred (foundation metadata concept)
Methotrexate sodium (substance) Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta (substance) Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta 166.667 microgram/mL solution for injection Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta 250 microgram/mL solution for injection Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta 500 microgram/mL solution for injection Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta 666.667 microgram/mL solution for injection Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta 833.333 microgram/mL solution for injection Preferred (foundation metadata concept)
Methoxy polyethylene glycol-epoetin beta only product Preferred (foundation metadata concept)
Methyl 2-cyanoacrylate Acceptable (foundation metadata concept)
Methyl 2-cyanoacrylate (substance) Preferred (foundation metadata concept)
Methyl 4-hydroxybenzoate Preferred (foundation metadata concept)
Methyl 4-hydroxybenzoate (substance) Preferred (foundation metadata concept)
Methyl carbamic acid 1-naphthyl ester Acceptable (foundation metadata concept)
Methyl hydroxybenzoate Acceptable (foundation metadata concept)
Methyl methacrylate Preferred (foundation metadata concept)
Methyl methacrylate (substance) Preferred (foundation metadata concept)

Start Previous Page 315 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start